Episode 23: Alnylam
カートのアイテムが多すぎます
カートに追加できませんでした。
ウィッシュリストに追加できませんでした。
ほしい物リストの削除に失敗しました。
ポッドキャストのフォローに失敗しました
ポッドキャストのフォロー解除に失敗しました
Episode 23: Alnylam
-
ナレーター：
-
著者：
このコンテンツについて
Send us a text
What if you could silence disease at its genetic root? That was the bold promise behind RNA interference (RNAi), one of the most groundbreaking scientific discoveries of the 21st century.
In this episode, we dive into the story of Alnylam Pharmaceuticals, from its founding by a powerhouse team of Nobel laureates, pioneering scientists, and biotech visionaries, to its transformation into the world’s first RNAi therapeutics company. We explore the challenges of turning a fragile lab discovery into medicine, the blockbuster drugs that redefined rare disease treatment, and the people who made it all possible.
Whether you’re a biotech enthusiast, a student of innovation, or just curious about how cutting-edge science becomes lifesaving therapy, this episode will take you inside the revolution that gave rise to RNAi medicines.
🎧 Listen now, stay curious, and don’t forget to subscribe for new episodes every Thursday!
#BiotechUnleashed #Alnylam #RNAi #BiotechPodcast #RareDisease #DrugDiscovery #BiotechHistory #GeneticMedicine
Support the show
© 2025 Petri Dish Perspectives LLC. All rights reserved.